Scientists Test New Skin Delivery for Mesothelioma Drug
Researchers at Griffith University are working on a new kind of mesothelioma treatment – one that could be delivered through the skin. The report in the Courier Mail makes reference to animal research on “certain small molecules” that reportedly have the potential to penetrate the skin and target the mitochondria of mesothelioma cells. Mitochondria are one of the most important power sources for cells, producing adenosine triphosphate, a source of chemical energy. The Griffith University project, under the leadership of Medical Professor Jiri Neuzil, is focusing on a drug that would be applied to the skin as a patch or cream. The drug would enter the blood stream through the skin and would target only mesothelioma cells. Studies of the … Continue reading Scientists Test New Skin Delivery for Mesothelioma Drug
A New Test for Mesothelioma?
Malignant pleural mesothelioma, an aggressive cancer of the pleural membrane that encases the lungs, can be difficult to diagnose. Early symptoms of the disease can be vague and mimic other lung conditions. But the longer a patient goes without a firm diagnosis, the poorer the prognosis is likely to be since mesothelioma is resistant to many traditional therapies. In addition to considering the patient’s symptoms and history of asbestos exposure, doctors often rely on biomarkers – compounds found in the blood or lung fluid – to pinpoint mesothelioma. Now, a group of Danish scientists are investigating a new biomarker that may eventually allow for an earlier, more accurate, mesothelioma diagnosis. Methylthioadenosine phosphorylase (MTAP) is a key enzyme used to help cells … Continue reading A New Test for Mesothelioma?